Advertisement

Topics

Dramatic decreases of all haemorrhagic coagulation factors by acquired inhibitors after extended left lobectomy.

07:00 EST 30th January 2019 | BioPortfolio

Summary of "Dramatic decreases of all haemorrhagic coagulation factors by acquired inhibitors after extended left lobectomy."

Acquired inhibition of coagulation factors is a rare disease, and the diagnosis is often difficult and delayed. We experienced a deficiency in all coagulation factors after hepatobiliary surgery.

Affiliation

Journal Details

This article was published in the following journal.

Name: International journal of surgery case reports
ISSN: 2210-2612
Pages: 140-144

Links

DeepDyve research library

PubMed Articles [16518 Associated PubMed Articles listed on BioPortfolio]

Presence of thrombophilia and levels of coagulation factors, coagulation inhibitors and TAFI do not affect global haemostasis or bleeding phenotype in patients with haemophilia A.

The issue of use parallelism factor method and index of circulating anticoagulant in diagnostic algorithm deficity of coagulation factors.

The paper presents the comparative use of algorithms to identify the causes of deficiency of coagulation factors in patients with a prolonged APTT, including the definition of the index of circulating...

The regulatory role of coagulation factors in vascular function.

The coagulation takes place in the hemostasis system and is a is hallmarked by a complex interplay of reactions between coagulation proteins. In the presence of a vascular breach, the conversion of pr...

Evaluating the Role of Promoter Methylation in Patients Predisposed to Hypercoagulable States via Methylation Specific PCR.

Hypercoagulable states (HS) can result from several different inherited and acquired disease conditions that cause abnormalities in the genes, proteins and cellular factors involved in the coagulation...

Assessing Blood Clotting and Coagulation Factors in Mice.

The mammalian blood coagulation system was designed to restrict blood loss due to injury as well as keep the blood fluid within the blood vessels of the organism. Blood coagulation activity in inbred ...

Clinical Trials [6012 Associated Clinical Trials listed on BioPortfolio]

Investigation of Coagulation Parameters in Hereditary Haemorrhagic Telangiectasia

The inherited disease hereditary haemorrhagic telangiectasia (HHT) causes bleeding from dilated fragile vessels, particularly in the nose and gut. However, many HHT patients develop deep v...

Perioperative Coagulation Management in Cardiac Surgery.

Cardiac surgery is bleeding requiring transfusion surgery . The haemorrhagic is related to the need to use high doses of anticoagulants to prevent thrombosis of blood . Moreover, this typ...

Coagulation Factor Changes Associated With Postpartum Hysterectomies

The purpose of this study is to examine components of the coagulation system in women undergoing postpartum hysterectomy and to compare laboratory parameters of coagulation in these women ...

Cross-sectional Study on Prevalence of Coagulation Factors Deficiency in Assiut University Children Hospital

Blood coagulation is a complex mechanism that is required for the rapid establishment of a stable fibrin clot. A series of interdependent enzyme-mediated reactions translate the molecular ...

A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors to Factor VIII or IX

The purpose of the study is to assess the safety, efficacy and pharmacokinetics of 2 separate dose regimens (75µg/kg and 225 µg/kg) of Coagulation Factor VIIa (Recombinant) for the tre...

Medical and Biotech [MESH] Definitions

Substances, usually endogenous, that act as inhibitors of blood coagulation. They may affect one or multiple enzymes throughout the process. As a group, they also inhibit enzymes involved in processes other than blood coagulation, such as those from the complement system, fibrinolytic enzyme system, blood cells, and bacteria.

The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot.

Endogenous substances, usually proteins, that are involved in the blood coagulation process.

An autosomal recessive characteristic or a coagulation disorder acquired in association with VITAMIN K DEFICIENCY. FACTOR VII is a Vitamin K dependent glycoprotein essential to the extrinsic pathway of coagulation.

Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions.

Advertisement
Quick Search
Advertisement
Advertisement

 


DeepDyve research library

Relevant Topic

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...


Searches Linking to this Article